The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer
Laura Naldi(University of Florence), Giada Marroncini(University of Florence)
Cited by 5
Related Papers
Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis
|Journal of Endocrinological Investigation|2022|10
The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells
|Journal of Endocrinological Investigation|2022|7
Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma
|International Journal of Molecular Sciences|2023|6
Effects of Reduced Extracellular Sodium Concentrations on Cisplatin Treatment in Human Tumor Cells: The Role of Autophagy
|International Journal of Molecular Sciences|2024|5
Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma
|Preprints.org|2023|3